Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02018068
Other study ID # 9202
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date January 14, 2014
Est. completion date July 27, 2016

Study information

Verified date July 2018
Source University Hospital, Montpellier
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Perineural injection of local anesthesic is currently the reference method for the treatment of post operative pain in a patient undergoing major orthopedic surgery. Postoperative pain is a dynamic phenomena in every patient. It is classified as intense during the first postoperative hours after surgery, and decreases in a non-linear manner over the days following the procedure. PCA (patient control analgesia) infusion of local anesthesic allows an adaptation of the local analgesia doses to the evaluated pain scores, as well as permit a decrease in adverse events related to the continuous infusion technique (motor or sensory blockade, paresthesia, etc.). The physician can also modify the pump settings according to the postoperative rehabilitation plan.The use of new communication techniques such as "telemedecine" may be of interest in reducing treatment onset time and optimizing pain management. The remote control consists to change the settings of the pump after if the anesthesiologist was informed in real time (via a smartphone or a tablet) on patient pain level, sensory and motor blockades. The physician goes to a dedicated website (Micrel CareTM). and makes the necessary changes by remote control via a GPRS (General Packet Radio Service) connexion. The aim of this prospective, comparative, multicentric trial is to compare the effectiveness of patient management through two communication modalities: remote control versus bedside care.


Recruitment information / eligibility

Status Terminated
Enrollment 72
Est. completion date July 27, 2016
Est. primary completion date July 27, 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients scheduled for elective orthopedic surgery

- Patients older than 18 years old

- Patient with a surgical indication (foot, shoulder or knee) which can require placement of a perineural catheter

- Patients classified ASA class I to III

- Informed consent

Exclusion Criteria:

- Contraindication to regional anesthesia or local anesthetics

- Contraindication to paracetamol, ketoprofen or morphine (depending on the selected rescue analgesia)

- Hospital discharge less than 48 hours after surgery

- Psychomotor disease (teletransmission contraindication)

- Patient undergoing surgery with a duration greater than 4 hours

- Patient with a duration of perineural catheter less than 48 hours

- Protected patient

- Patient enrolled in another study

- Patient who can't understand local language

Study Design


Intervention

Other:
Remote control
When pain or sensory and motor block evaluation exceed the thresholds, the patient enters the data in the PCA (patient Control Analgesia) pump. The investigator is alerted by SMS on his smartphone and makes the necessary programming changes by remote control on the Micrel Care TM site. Systematic assessments via the PCA pump are scheduled for 9:00, 13:00 and 19:00 every day during 48 to 72 hours. The patient can alert his physician through his PCA pump of any additional requests (pain, motor blockade, numbness). The anesthesiologist receives an SMS alert and can make any necessary programming changes to the pump via the remote control.
At bedside care
When pain or sensory and motor block evaluation exceed the thresholds, the nurse contacts the physician and she will be able to modify the pump settings according to the anesthesiologist prescription. The delay between the call of the patient and the programming changes, the duration of the procedure are reported. Systematic evaluations via the PCA (Patient Control Analgesia) pump are done when the patient arrives in this surgical ward and at 9:00, 13:00 and 19:00 every day for 48 to 72 hours.Throughout the study, if necessary, the nurse or referring physician performs the programming changes directly on the PCA pump and notes the delay in treatment. All the reasons and the duration of any bedside visit are reported.

Locations

Country Name City State
France Department of Anesthesiology and critical care, Lapeyronie University Hospital Montpellier
France Anesthesia Réanimation Department, Hôpital Saint Roch Nice
Netherlands A Schweitzer Hospital Dordrecht
United Arab Emirates Rachid Hospital Dubaï

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Montpellier

Countries where clinical trial is conducted

France,  Netherlands,  United Arab Emirates, 

Outcome

Type Measure Description Time frame Safety issue
Primary Time between the patient's call and the change in Patient Control Analgesia (PCA) pump settings from arriving at the ward after surgery until 72 postoperative hours
Secondary Number of nursing interventions from arriving at the ward after surgery until 72 postoperative hours
Secondary Duration of nursing interventions from arriving at the ward after surgery until 72 postoperative hours
Secondary Post operative pain measured by VAS (Visual Analog Scale) from before implementation of PCA until 72 postoperative hours
Secondary Amount of rescue analgesia from implementation of PCA (Patient Control Analgesia) until 72 postoperative hours
Secondary Patient satisfaction Score at catheter removal (at 72 postoperative hours) at 72 postoperative hours
Secondary Time until the start of physical therapy from surgery until 72 postoperative hours
Secondary the physiotherapist's satisfaction scores at 72 postoperative hours
Secondary Healthcare staff (nurse and physician) satisfaction scores at 72 postoperative hours
Secondary Duration of hospital stay At the end of hospital stay (an expected average of 72 postoperative hours)
Secondary Overall cost of patient management strategy until end of postoperative patient management (an average of 72 postoperative hours)
See also
  Status Clinical Trial Phase
Completed NCT05480111 - The Role of Quadratus Lumborum Blocks Following Minimally Invasive Hysterectomy Phase 4
Completed NCT06129305 - Erector Spina Muscle Distance From the Skin at Different Thoracal Elevations
Completed NCT04401826 - Micro-surgical Treatment of Gummy Smile N/A
Recruiting NCT04020133 - the Role of Popliteal Plexus Block in Pain Management After Anterior Cruciate Ligament Reconstruction. N/A
Completed NCT03023462 - Efficacy of an Anterior Quadratus Lumborum Block vs. a TAP-block for Inguinal Hernia Repair N/A
Completed NCT03652103 - Efficiency of Erector Spinae Plane Block For Patients Undergoing Percutaneous Nephrolithotomy Phase 4
Completed NCT03546738 - Spinal Cord Burst Stimulation for Chronic Radicular Pain Following Lumbar Spine Surgery N/A
Terminated NCT03261193 - ITM + Bupivacaine QLB vs. ITM + Sham Saline QLB for Cesarean Delivery Pain Phase 3
Withdrawn NCT03528343 - Narcotic vs. Non-narcotic Pain Regimens After Pediatric Appendectomy Phase 1/Phase 2
Completed NCT02525133 - Phase 3 Study of Efficacy and Safety of the XaraColl® Bupivacaine Implant After Hernioplasty Phase 3
Completed NCT03244540 - Regional Analgesia After Cesarean Section Phase 4
Enrolling by invitation NCT05316168 - Post Operative Pain Management for ACL Reconstruction Phase 3
Recruiting NCT04130464 - Intraperitoneal Infusion of Analgesic for Postoperative Pain Management Phase 4
Enrolling by invitation NCT04574791 - Addition of Muscle Relaxants in a Multimodal Analgesic Regimen for Analgesia After Primary Total Knee Arthroplasty N/A
Completed NCT04073069 - Scalp Infiltration With Diprospan Plus Ropivacaine for Postoperative Pain After Craniotomy in Adults Phase 4
Completed NCT04526236 - Influence of Aging on Perioperative Methadone Dosing Phase 4
Recruiting NCT05351229 - Intrathecal Morphine for Analgesia in Video-assisted Thoracic Surgery Phase 4
Enrolling by invitation NCT05543109 - Ultrasound Guided Psoas Compartment Block vs Suprainguinal Fascia Iliaca Compartment Block N/A
Completed NCT05346588 - THRIVE Feasibility Trial Phase 3
Completed NCT04919317 - Combination Dexamethasone and Bupivacaine Pain Control in Reduction Mammaplasty Phase 2